Essential Hypertension: all 538 studies
Page 5 of 6. Open to participants first (76), then studies with results posted, then the rest; newest registration first within each.
- Vascular Impact of Omega-3 in Metabolic SyndromeCompletedNCT01566188Not applicable
- Efficacy and Safety of HL-040XC in Essential Hypertension and HyperlipidemiaCompletedNCT01541943Phase 3
- Effectiveness of Viscum Album Mother Tincture as an Anti-hypertensive in Essential HypertensionCompletedNCT01527760Not applicable
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential HypertensionCompletedNCT01523067Phase 1
- Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential HypertensionCompletedNCT01518855Phase 4
- Renal Sympathectomy in Treatment Resistant Essential Hypertension, a Sham Controlled Randomized TrialCompletedNCT01459900Not applicable
- Evaluation of Regional Myocardial Dynamics at Physical Stress in Essential HypertensionCompletedNCT01442116Not applicable
- Renal Sympathetic Modification in Patients With Essential HypertensionStatus unknownNCT01417221Not applicable
- Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With HypertensionStatus unknownNCT01413048Phase 3
- Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life SettingCompletedNCT01392534
- LFF269 Compared to Placebo After Treatment in Subjects With Essential HypertensionTerminatedNCT01373086Phase 2
- High Dose BAYA1040 CR: a Long Term Extension StudyCompletedNCT01355367Phase 3
- Pivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, FedCompletedNCT01350609Phase 1
- The Effect of Metformin on the Correlation Between Hyperinsulinemia and HypertensionCompletedNCT01342614Not applicable
- Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene MutationsStatus unknownNCT01320397Phase 2
- Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential HypertensionCompletedNCT01303783Phase 2
- The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients.CompletedNCT01295021
- High Dose BAYA1040_Nifedipine: a Long Term Combination StudyCompletedNCT01294215Phase 3
- Fimasartan (BR-A-657) Multiple Oral Dose in Healthy SubjectsCompletedNCT01289899Phase 1
- Fimasartan (BR-A-657) Single Oral Dose in Healthy SubjectsCompletedNCT01289886Phase 1
- Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential HypertensionCompletedNCT01289132Phase 2
- High Dose BAYA1040_Nifedipine: a Dose-comparative StudyCompletedNCT01287260Phase 3
- Essential HypertensionCompletedNCT01264692Phase 2
- A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapyCompletedNCT01258673Phase 3
- A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by MonotherapyCompletedNCT01241487Phase 4
- Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential HypertensionCompletedNCT01237873Phase 3
- Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting ConditionsCompletedNCT01227603Phase 1
- Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)HypertensionCompletedNCT01198249Phase 1
- The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular VariablesCompletedNCT01195805Not applicable
- Intensive Vasodilator Therapy in Patients With Essential HypertensionCompletedNCT01180413Phase 4
- A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy VolunteersCompletedNCT01146938Phase 1
- The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential HypertensionCompletedNCT01135212Phase 3
- The Confirmatory Olmesartan Plaque Regression StudyTerminatedNCT01132768Phase 4
- Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential HypertensionCompletedNCT01131546Phase 4
- Effects of Atorvastatin on Blood Pressure and Urinary Albumin ExcretionCompletedNCT01126684Not applicable
- Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential HypertensionCompletedNCT01122251Phase 2
- The Link Between Human Cytomegalovirus (HCMV) and HypertensionStatus unknownNCT01113359
- Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus AmlodipineCompletedNCT01113047Phase 3
- Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential HypertensionCompletedNCT01093807Phase 2
- Resistant Arterial Hypertension Cohort StudyCompletedNCT01083017
- Jiangzhuo Qinggan Prescription and Irbesartan in the Treatment of Essential Hypertension(Hepatogastric Damp-heat)Clinical StudyStatus unknownNCT01082835
- Specificity of Elevated Plasma EM66 Levels in PheochromocytomaCompletedNCT01022515Not applicable
- Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fed ConditionsCompletedNCT01013155Not applicable
- Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fasted ConditionsCompletedNCT01012687Not applicable
- Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive PatientsStatus unknownNCT01011660Phase 4
- Monotherapy Versus Dual Therapy for Initial Treatment for HypertensionStatus unknownNCT00994617Phase 4
- A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male VolunteersCompletedNCT00991783Phase 1
- A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male VolunteersCompletedNCT00991705Phase 1
- Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential HypertensionTerminatedNCT00980031Not applicable
- Efficacy and Safety of Amlodipine and Losartan in Patients With Essential HypertensionCompletedNCT00942344Phase 2
- Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential HypertensionCompletedNCT00940680Phase 3
- Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential HypertensionCompletedNCT00940667Phase 3
- A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male VolunteersCompletedNCT00938262Phase 1
- A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male VolunteersCompletedNCT00938197Phase 1
- A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male VolunteersCompletedNCT00938132Phase 1
- Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K)CompletedNCT00937651Phase 2
- Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male VolunteersCompletedNCT00937534Phase 1
- Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension PatientsCompletedNCT00923611Phase 2
- A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male VolunteersCompletedNCT00923533Phase 1
- Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH)CompletedNCT00882947
- Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential HypertensionCompletedNCT00872586Phase 3
- Importance of Aldosterone in the Pathogenesis of Hypertensive Heart DiseaseCompletedNCT00865501Phase 3
- Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential HypertensionCompletedNCT00856271Phase 3
- Home Blood Pressure in Hypertension ManagementStatus unknownNCT00841308Phase 4
- A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual ComponentsCompletedNCT00819104Phase 4
- In-practice Evaluation of Atacand 16mg Antihypertensive EffectCompletedNCT00802542
- China Stroke Primary Prevention TrialCompletedNCT00794885Phase 4
- Loaded Breathing Training in Essential HypertensionTerminatedNCT00791986Not applicable
- A Dose-Ranging Study of the Safety and Efficacy of ADX415 in the Treatment of Essential HypertensionCompletedNCT00779181Phase 2
- Efficacy and Safety of Azilsartan in Subjects With Essential HypertensionCompletedNCT00759551Phase 2
- Olmesartan Medoxomil Versus Losartan in Elderly and Very ElderlyCompletedNCT00751751Phase 3
- Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk AssessmentCompletedNCT00741585Phase 4
- Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive PatientsStatus unknownNCT00716950Phase 4
- Safety, Tolerability and Efficacy of a Vaccine Against Essential HypertensionCompletedNCT00710372Phase 2
- Efficacy and Safety of Weak Extremely Low Frequency Electromagnetic Fields in Mild and Moderate Essential HypertensionCompletedNCT00709930Phase 2
- Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Exploratory Efficacy of a Vaccine Against Essential HypertensionCompletedNCT00701649Phase 2
- To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential HypertensionCompletedNCT00662896Phase 1
- Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left VentricularStatus unknownNCT00659451Phase 3
- Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate HypertensionStatus unknownNCT00644475Phase 3
- Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential HypertensionCompletedNCT00638911
- Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/HydrochlorothiazideCompletedNCT00608153
- Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVHCompletedNCT00607633
- Efficacy Observational Study of Candesartan Cilexetil on Hypertensive PatientsCompletedNCT00573742
- Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive TabletsCompletedNCT00553865Phase 2
- Sympathetic Overactivity in Essential HypertensionWithdrawnNCT00541619
- Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on AmlodipineCompletedNCT00509470Phase 4
- Safety, Tolerability, Pharmacodynamic Effects and Preliminary Evidence for Efficacy of the Anti-Hypertension Vaccine CYT006-AngQbCompletedNCT00500786Phase 1/2
- Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential HypertensionCompletedNCT00461903Phase 3
- Nijmegen Antihypertensive Management Improvement StudyCompletedNCT00457483Phase 4
- Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential HypertensionTerminatedNCT00449618Phase 4
- An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325)TerminatedNCT00449111Phase 3
- Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)CompletedNCT00446524Phase 3
- A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary HypertensionTerminatedNCT00444834Phase 2
- The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential HypertensionCompletedNCT00438945Phase 4
- Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential HypertensionCompletedNCT00424541Phase 1
- Efficacy of Rostafuroxin in the Treatment of Essential HypertensionCompletedNCT00415038Phase 2
- Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in Hypertension: The StayOnDiur StudyCompletedNCT00408512Phase 4
- Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential HypertensionStatus unknownNCT00380289Not applicable
- Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential HypertensionCompletedNCT00367094Phase 3
- Safety and Efficacy of Ramipril in the Treatment of Essential HypertensionStatus unknownNCT00366119Phase 4